Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SMS Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2026 was ₹13,624 Mil.
During the past 12 months, SMS Pharmaceuticals's average Total Assets Growth Rate was 18.20% per year.
During the past 3 years, the average Total Assets Growth Rate was 14.60% per year.
During the past 5 years, the average Total Assets Growth Rate was 11.20% per year.
During the past 10 years, the average Total Assets Growth Rate was 11.50% per year.
During the past 13 years, SMS Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 34.50%. The lowest was -2.90%. And the median was 11.00%.
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
SMS Pharmaceuticals's Asset Turnover for the quarter that ended in Mar. 2026 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
SMS Pharmaceuticals Total Assets Related Terms
SMS Pharmaceuticals Total Assets Historical Data
* Premium members only.
The historical data trend for SMS Pharmaceuticals's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
SMS Pharmaceuticals's Total Assets for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SMS Pharmaceuticals (BOM:532815) has a Total Assets of ₹13,624 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on SMS Pharmaceuticals and its competitors.
Is SMS Pharmaceuticals' Total Assets too high?
SMS Pharmaceuticals' current Total Assets is ₹13,624 Mil. Overall, SMS Pharmaceuticals has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SMS Pharmaceuticals' Total Assets compare to LLY and JNJ?
SMS Pharmaceuticals' Total Assets of ₹13,624 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on SMS Pharmaceuticals and its competitors. SMS Pharmaceuticals's current Total Assets is ₹13,624 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMS Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, SMS Pharmaceuticals (BOM:532815) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹263.04, compared to a current price of ₹376.95 — trading 43.3% above its estimated fair value. The current Total Assets is ₹13,624 Mil. SMS Pharmaceuticals' overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For SMS Pharmaceuticals (BOM:532815), the current Total Assets is ₹13,624 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMS Pharmaceuticals (BOM:532815) Overvalued in 2026?
Based on GuruFocus' analysis, SMS Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹376.95 is trading 43.3% above its estimated GF Value™ of ₹263.04.
GuruFocus considers SMS Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for BOM:532815:
Total Assets: ₹13,624 Mil
GF Value™: ₹263.04 vs. price of ₹376.95 (43.3% above fair value)
No single metric tells the full story. See the BOM:532815 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SMS Pharmaceuticals Ltd is a drug manufacturing company. It is engaged in the business of manufacturing Active Pharma Ingredients and their intermediates. Its product portfolio includes drugs for anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, anti-viral, and other conditions.
78GF Score
Get the complete analysis for BOM:532815
Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532815 has been successfully added to your 
